Calidi Biotherapeutics (CLDI) Announces CEO Change

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/9/2026

1. HUM
2. SPCX
3. ALHC
4. T
5. PEP
6. CVS
7. UNH
8. TMUS
9. VZ
10. SPY

Go back to Calidi Biotherapeutics (CLDI) Announces CEO Change

Calidi Biotherapeutics Announces Chief Executive Officer Transition and Appointment of Eric Poma, Ph.D. as CEO and Director

April 23, 2025 8:00 AM EDT

SAN DIEGO, April 23, 2025 (GLOBE NEWSWIRE) -- Calidi Biotherapeutics Inc. (NYSE American: CLDI) (Calidi), a clinical-stage biotechnology company developing a new generation of targeted antitumor virotherapies, today announced the succession of its Chief Executive Officer (CEO), Allan Camaisa, to Eric Poma, Ph.D., who was appointed as CEO and member of the Board of Directors of Calidi (Board), effective April 22, 2025. Mr. Camaisa will continue to serve as a member of the Board.

We are pleased to welcome Eric as Calidis new CEO, given his deep experience in life science leadership with a focus on oncology, as Calidi advances its systemic... More